NAICS Code 325412-02 - Drug (Manufacturing)

Marketing Level - NAICS 8-Digit

Business Lists and Databases Available for Marketing and Research

Total Verified Companies: 195
Contact Emails: 39,316
Company Websites: 186
Phone Numbers: 149
Business Addresses: 195
Companies with Email: 101
Get Business List
NAICS CODE 325412-02
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead
Ideal for: Direct Mailing Email Campaigns Calling Market Research ‐ Free Sample & Report, Custom Lists, and Expert Support — All Included
Looking for more companies? See NAICS 325412 - Pharmaceutical Preparation Manufacturing - 1,726 companies, 213,574 emails.

NAICS Code 325412-02 Description (8-Digit)

The Drug (Manufacturing) industry is a subdivision of the Pharmaceutical Preparation Manufacturing industry, which involves the production of drugs for human and animal use. This industry includes the manufacturing of prescription and over-the-counter drugs, as well as biologics, vaccines, and other pharmaceutical products. The process of drug manufacturing involves a range of activities, including research and development, clinical trials, formulation, production, packaging, and distribution.

Parent Code - Official US Census

Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 325412 page

Tools

Tools commonly used in the Drug (Manufacturing) industry for day-to-day tasks and operations.

  • High-performance liquid chromatography (HPLC)
  • Gas chromatography (GC)
  • Mass spectrometry (MS)
  • Nuclear magnetic resonance (NMR) spectroscopy
  • Infrared (IR) spectroscopy
  • Ultraviolet-visible (UV-Vis) spectroscopy
  • Particle size analyzers
  • Dissolution testers
  • Stability chambers
  • Lyophilizers
  • Autoclaves
  • Fermenters
  • Mixers
  • Granulators
  • Tablet presses
  • Capsule fillers
  • Coating machines
  • Labeling machines
  • Blister packaging machines

Industry Examples of Drug (Manufacturing)

Common products and services typical of NAICS Code 325412-02, illustrating the main business activities and contributions to the market.

  • Antibiotics (Manufacturing)
  • Antidepressants (Manufacturing)
  • Antihistamines (Manufacturing)
  • Antipsychotics (Manufacturing)
  • Blood products (Manufacturing)
  • Chemotherapy drugs (Manufacturing)
  • Hormones (Manufacturing)
  • Insulin (Manufacturing)
  • Pain relievers (Manufacturing)
  • Vaccines (Manufacturing)

History

A concise historical narrative of NAICS Code 325412-02 covering global milestones and recent developments within the United States.

  • The "Drug (Manufacturing)" industry has a long and rich history dating back to ancient times. The first recorded use of drugs dates back to 2600 BC in China, where the use of herbal remedies was common. In the 19th century, the development of synthetic drugs revolutionized the industry, and the first modern drug, aspirin, was introduced in 1899. In the United States, the Pure Food and Drug Act of 1906 was a significant milestone in the industry, as it required drugs to be labeled with their ingredients and dosage. In the 20th century, the industry continued to grow, with the development of antibiotics, vaccines, and other life-saving drugs. In recent years, the industry has faced challenges such as rising drug prices and the opioid epidemic, but it continues to be a vital part of the healthcare system. Recent history in the United States has been marked by a focus on innovation and research. The industry has seen significant investment in new technologies such as gene therapy and personalized medicine. The FDA has also streamlined the drug approval process, allowing for faster development and approval of new drugs. However, the industry has also faced criticism for high drug prices and the role of pharmaceutical companies in the opioid epidemic. Overall, the "Drug (Manufacturing)" industry in the United States has a complex and evolving history, with both successes and challenges.